“Conclusions Formononetin enhances the tumoricidal effect of everolimus by inhibiting the activity of Akt.”
“The apoptosis ratio in cells treated with formononetin and everolimus increased by 27.9%.”
“The combination of formononetin and everolimus resulted in a 2-fold decrease in tumor volume and a 21.6% decrease in cell survival.”
“The results showed that formononetin enhances the efficacy of everolimus in suppressing breast cancer cell growth both in vitro and in vivo.”
“We evaluated the efficacy of formononetin in improving the tumoricidal effect of everolimus by suppressing the mTOR pathway in breast cancer cells.”